Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

Lymphoma

The goal of this clinical study is test how well the study drug, axicabtagene ciloleucel,
works in participants with relapsed/refractory follicular lymphoma

Disease Sites: Lymphoma

Phase: III

Investigator: Oluwole, Olalekan

NCTID: NCT05371093

Protocol No: VICCCTT2266

Learn More

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

Lymphoma

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma

Lymphoma

Clinical Trial Flowcharts for Referring Physicians

Clinical Trial Flowcharts for VICC Staff (VUNetID required)

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)